Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 25, 2017
Bioblast Announces Effectiveness of Five to One Reverse Split
TEL AVIV, Israel, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of a five ...
September 25, 2017
Key Clinical Study Showing Reversal of Refractory Septic Shock in Patients Treated with CytoSorb®
MONMOUTH JUNCTION, N.J., Sept. 25, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in ...
September 25, 2017
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results
CRANBURY, N.J., Sept. 25, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
September 25, 2017
iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017
NASHUA, N.H. and SAN DIEGO, Sept. 25, 2017 (GLOBE NEWSWIRE) --  (Booth #3139) - iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions ...
September 25, 2017
Paratek Pharmaceuticals to Present New Omadacycline Data at IDWeek 2017
BOSTON, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) announced today that new data from its omadacycline clinical and microbiology programs will be ...
September 25, 2017
Soleno Therapeutics Announces Receipt of Scientific Advice from the European Medicines Agency for DCCR in Prader-Willi Syndrome
REDWOOD CITY, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 25, 2017
BIOPHYTIS filed IND application for approval by FDA of SARA-INT Phase 2b study of Sarconeos in Sarcopenia
PARIS, Sept. 25, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, ...
September 25, 2017
Catalyst Biosciences Announces Successful Completion of First Subcutaneous Dosing Cohort in Ongoing Hemophilia B Clinical Trial
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced that its collaborator ISU Abxis has completed dosing of the first ...
September 25, 2017
Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of EDSIVO™ (celiprolol) for Treatment of Vascular Ehlers-Danlos Syndrome
CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
September 25, 2017
AzurRx Announces Appointment of Maged Shenouda as Chief Financial Officer
NEW YORK, Sept. 25, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”) a company specializing in the development of non-systemic, recombinant  ...
September 25, 2017
Gemphire to Present New COBALT-1 Clinical Data at the 2017 FH Global Summit
LIVONIA, Mich., Sept. 25, 2017 (GLOBE NEWSWIRE) --  Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
September 21, 2017
Lysogene Holds First Parent Advisory Board in MPS IIIA
PARIS & CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Regulatory News: Lysogene (FR0013233475 – LYS) (LYS.PA), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system ...
September 21, 2017
BioTime Co-CEO Adi Mohanty to Participate in Panel Discussion at the Cell & Gene Therapy CEO Forum
ALAMEDA, Calif.-- (BUSINESS WIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Co-Chief ...
September 21, 2017
Omadacycline Receives Qualified Infectious Disease Product Designation from FDA for an Additional Indication in Uncomplicated Urinary Tract Infections
BOSTON, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
September 21, 2017
Lipocine Announces Motions Decision by USPTO in Interference Against Clarus
SALT LAKE CITY , Sept. 21, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that the Patent Trial and Appeal ...
September 21, 2017
Krystal Biotech Announces Presentation of KB103 Data at EB2017 - The 5th World Conference of EB Research
PITTSBURGH, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (“Krystal”)(KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering ...
September 21, 2017
Rexahn Pharmaceuticals to Present at the 2017 Disruptive Growth Company Showcase NYC
ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment ...
September 21, 2017
Advaxis to Webcast Company Overview at the Cantor Fitzgerald Global Healthcare Conference
PRINCETON, N.J.-- (BUSINESS WIRE) -- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced its company ...
September 20, 2017
DelMar Pharmaceuticals Announces $10 Million Registered Direct Offering Priced At-The-Market
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 20, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the ...
September 20, 2017
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2017 Results; Teleconference and Webcast to be held on September 25, 2017
CRANBURY, N.J., Sept. 20, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter and fiscal year end 2017 operating results ...
Page 91 of 117